STAT3 and Miyoshi myopathy: Similar to some other STAT3 inhibitors, SC09 also overcomes chemoresistance in MM cells and enhances therapeutic efficacy of other known anti-MM drugs by suppressing both IL-6-induced and endogenous activity of STAT3.